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Individual RelyNF-kB transcription factors, although dispensable
for the development and maturation of most hemopoietic cells, are
critical regulators of normal immune function. Redundancy among
these proteins prompted us to examine the role of Rel and RelA in
hemopoiesis by using mice that lack both subunits. Because of the
death of double-mutant fetuses at day 13.5 of gestation (E13.5),
E12 fetal liver hemopoietic progenitors were used for in vitro
cultures and for repopulating stem cell studies in lethally irradiated
normal recipient mice. Most striking, RelyRelA-deficient hemopoi-
etic precursors failed to promote the survival of myeloablated
mice. This phenotype was associated with several defects including
a reduction of spleen colony-forming unit progenitors, impaired
erythropoiesis, and a deregulated expansion of granulocytes. In
vitro progenitor assays also revealed that Rel or RelA serves an
antiapoptotic role during monocyte differentiation. Despite the
combined loss of Rel and RelA leading to these hemopoietic
defects, c-rel2y2rela2y2 stem cells contributed to the development
of all lineages in mice engrafted with double-mutant fetal liver
cells and normal bone marrow cells, albeit in a reduced fashion
compared with controls. Collectively, these data indicate the loss of
Rel and RelA does not appear to affect pluripotent stem cells;
rather, Rel and RelA serve redundant functions in regulating
differentiation and survival of committed progenitors in multiple
hemopoietic lineages.
RelyNF-kB transcription factors are homo- and heterodimericproteins composed of related subunits that bind decameric
sequences (kB elements) located within promoters and enhanc-
ers of cellular genes, particularly those encoding proteins in-
volved in immune, acute phase and inflammatory responses (1).
Each subunit shares a conserved N-terminal domain that en-
compasses sequences required for DNA binding, dimerization,
and nuclear localization. In mammals, each of the five subunits,
NF-kB1(p50), NF-kB2(p52), RelA (p65), RelB, and Rel is
encoded by a different gene (1, 2). Rel, RelA, and RelB each
possess distinct carboxyl-terminal transactivation domains,
whereas NF-kB1 and NF-kB2, which only consist of the con-
served N-terminal domain, lack intrinsic transcriptional trans-
activating properties (1, 2). In most cell types, the major pro-
portion of RelyNF-kB is retained in the cytoplasm in an inactive
complex with regulatory IkB proteins (3, 4). Cytoplasmic Rely
NF-kB proteins are translocated to the nucleus in response to
diverse stimuli that activate an IkB kinase complex, which, in
turn, phosphorylates the IkB isoforms (5), targeting these pro-
teins for ubiquitin-dependent, proteosome-mediated degrada-
tion (3, 4).
Mice homozygous for null mutations in genes encoding Rely
NF-kB subunits have revealed the unique roles of each tran-
scription factor (6). RelA is essential for embryonic develop-
ment, with rela2y2 fetuses dying at day 15 (E15) of gestation
because of apoptosis of fetal hepatocytes (7, 8). Rel, RelB,
NF-kB1, or NF-kB2, although dispensable for embryogenesis,
are important for the function andyor development of hemo-
poietic cells (9). Of relevance to this study, neither Rel nor RelA
is essential for the generation or maturation of hemopoietic cells
(7, 8, 10). Instead, the loss of either transcription factor leads to
activation defects in mature B cells, T cells, and macrophages (9),
indicating critical roles in regulating genes induced during
immune responses.
Despite the unique roles ascribed to individual RelyNF-kB
subunits, similarities among these proteins may prevent certain
phenotypes from being revealed in the single mutant mice
because of compensation by other family members. This notion
is supported by the finding that mice lacking two RelyNF-kB
subunits exhibit novel phenotypes or exaggerated versions of
those seen in the single mutants. Examples include the blockage
of lymphocyte development in the absence of NF-kB1 and RelA
(11), greater severity of inflammatory disease in nfkb12y2y
relb2y2 mice than observed in relb2y2 animals (12), and impaired
osteoclast and B cell development in nfkb12y2nfkb22y2 mice
(13, 14). Because Rel and RelA are the major transactivating
RelyNF-kB subunits expressed in hemopoietic cells (1, 2) and
RelAyRel heterodimers have been implicated in transcriptional
regulation (15), we chose to examine the differentiation of
hemopoietic cells that lack both subunits. Fetal liver c-rel2y2
rela2y2 hemopoietic precursors were used in clonal agar assays
and transplantation studies to show that RelyNF-kB transcrip-
tion factors play a role in erythropoiesis, the regulation of
granulopoiesis, and the survival of monocytic cells.
Materials and Methods
Fetal Liver Cell Engraftment. The c-rel2y2 (10) and rela2y2 (7) mice
used in this study were backcrossed for more than nine gener-
ations with C57BLy6-Ly5.2 mice. For hemopoietic cell recon-
stitutions, between 3 3 105 and 1 3 107 viable cells from E12
fetal liver were injected into the tail veins of 8- to 10-week-old
C57BLy6-Ly5.1 mice that had received 1,100 rad of g-irradia-
tion. For coreconstitutions, irradiated C57BLy6-Ly5.1 mice re-
ceived 1 3 106 to 1 3 107 E12 C57BLy6-Ly5.2 fetal liver cells and
2–7 3 105 adult C57BLy6-Ly5.1 bone marrow cells. Mice were
maintained on autoclaved water containing 100 mgyml neomy-
cin sulfate. Fetuses of the desired genotype, confirmed by PCR,
were derived from c-rel1y1rela1y2 3 c-rel1y1rela1y2 and
c-rel2y2rela1y2 3 c-rel2y2rela1y2 matings.
Spleen Colony-Forming Unit (CFU-S) Assays. CFU-S assays were
performed essentially as described (16). Briefly, irradiated
C57BLy6-Ly5.1 mice were injected with 1–3 3 105 E12 fetal liver
cells and recipients were sacrificed 12 days postengraftment.
Spleens were fixed in Carnoy’s solution (60% ethanoly30%
chloroformy10% acetic acid), and the number of macroscopic
colonies were counted.
Immunofluorescence Staining, Flow Cytometry, Cell Sorting, and
Morphological Analysis of Cells. Dispersed cells from the bone
marrow, blood, thymus, and spleen of mice reconstituted with
Abbreviations: E, embryonic day; CFU-S, spleen colony-forming unit.
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bone marrow andyor fetal liver hemopoietic precursors were
stained with fluorochrome-labeled or biotinylated mAbs as
described (17). Five thousand viable cells (negative for pro-
pidium iodide staining) then were analyzed by using a FACScan
flow cytometer (Becton Dickinson). Fetal liver-derived macro-
phages were purified from the bone marrow of engrafted mice
on a FACS Star II by three-color cell sorting by using anti-Mac-1,
anti-Gr-1, and anti-Ly5.2 mAbs. The antibodies used in this study
were: Ly5.2(5.430–15.2), Ly5.1(A201.7), Ter119, Gr-1(8CS),
Mac-1(M1y76), F4y80, B220(RA3–6B2), Thy-1.2(30H12), Sca-
1(E13.6.7), c-Kit(ACK-2), CD34(RAM34), CD44(IM781), and
AA41. Cytospin preparations were stained with May Grunwald–
Giemsa.
Fetal Liver Cultures. Suspensions of fetal liver cells were cultured
in 35-mm Petri dishes by using 10,000 cells in 1-ml volumes of
DMEM containing 20% newborn calf serum and 0.3% agar.
Cultures were stimulated by adding purified recombinant murine
growth factors at the following concentrations: granulocytey
macrophage colony-stimulating factor, granulocyte colony-
stimulating factor, and IL-3 at 10 ngyml, IL-6 at 500 ngyml, stem
cell factor at 100 ngyml, erythropoietin at 20 unitsyml, leukemia
inhibiting factor at 10 ngyml, and Flk ligand at 500 ngyml.
Cultures were incubated at 37°C in a fully humidified atmo-
sphere of 10% CO2 in air for 7 days and then fixed and stained.
All colonies (defined as .50 cells) were counted and typed at a
magnification of 3400.
Results
Absence of Rel Accelerates the Onset of Embryonic Death in RelA-
Deficient Mice. Consistent with previous reports (7, 8), rela2y2
fetuses developed normally until ’E14.0, after which hepatic
apoptosis, subsequent abdominal hemorrhage, and necrosis en-
sued. This phenotype was observed in c-rel2y2rela2y2 fetuses,
but occurred earlier in gestation, with fetal liver degeneration
and hemorrhaging evident in most double-mutant fetuses by
E13.5 (Table 1). Acceleration of the rela2y2 phenotype also
occurred in nfkb12y2rela2y2 mice (11). These findings suggest
that Rel complexes partially compensate for RelA in fetal liver.
Hemopoietic Progenitor Cells from c-rel2y2rela2y2 Fetal Liver Fail to
Promote Survival of Lethally Irradiated Mice. The combined roles of
Rel and RelA in hemopoiesis first were assessed by injecting
Ly5.2-positive fetal liver cells from E12 c-rel2y2rela2y2 fetuses
into lethally irradiated C57BLy6-Ly5.1 mice. Whereas ’86% of
lethally irradiated mice receiving control (wild-type, rela2y2 or
c-rel2y2) fetal liver cells survived for longer than 8 weeks, all
animals engrafted with c-rel2y2rela2y2 cells were sacrificed
between 12 and 22 days postirradiation because of their mori-
bund condition (Fig. 1). Whereas 3 3 105 control cells were
sufficient to promote survival after lethal irradiation, up to
25-fold more c-rel2y2rela2y2 cells failed to successfully engraft
irradiated mice. Moreover, the period that recipients survived
after c-rel2y2rela2y2 fetal liver cell engraftment was in direct
proportion to the number of donor cells, with those mice
receiving more cells surviving longer. This failure of c-rel2y2
rela2y2 fetal liver cell engraftment did not simply reflect a
reduction in the number and viability of cells from the E12
fetuses, because histology, propidium iodide exclusion, and flow
cytometric analysis of hemopoietic precursors revealed no dif-
ference between E12 control and c-rel2y2rela2y2 fetal liver cells
(M.G., unpublished results).
The successful engraftment of hemopoietic cells into lethally
irradiated recipients encompasses two phases that utilize distinct
precursor populations. The initial transient engraftment re-
quires precursors that reside in the CFU-S compartment,
whereas long-term reconstitution is dependent on more primi-
tive stem cells (18). Because the rapid death of recipients
injected with c-rel2y2rela2y2 cells indicated a defect in transient
engraftment, the frequency of CFU-S in E12 control and
Fig. 1. Hemopoietic precursors in c-rel2y2rela2y2 fetal liver fail to promote
the survival of lethally irradiated mice. The period of survival for lethally
irradiated C57BLy6-Ly5.1 mice engrafted with E12 c-rel2y2rela2y2 (19 recipi-
ents, F) or control (36 recipients: c-rel1y1rela1y1, n 5 8; c-rel1y1rela1y2, n 5 6;
c-rel1y1rela2y2, n 5 6; c-rel2y2rela1y1, n 5 16, E) fetal liver cells suspensions
is presented as a Kaplan–Meyer plot. After engraftment, irradiated recipients
were monitored daily and sacrificed for analysis before imminent death.
Irradiated mice received a mean of 31 6 17 3 105 (range 3–80 3 105) and 36 6
20 3 105 (range 5–80 3 105) control or c-rel2y2rela2y2 cells, respectively. Mice
receiving between 3 3 105 and 2 3 106 c-rel2y2rela2y2 cells had to be sacrificed
after 12–16 days engraftment, whereas recipients of 4–8 3 106 double-
mutant cells survived for 19–22 days.
Table 1. Accelerated prenatal death of c-rel2y2rela2y2 fetuses
Genotype
Embryonic day
12.0 13.0 13.5 14.0 14.5 15.0
c-rel1y1rela2y2 Normal
morphology
(4y4)
Normal
morphology
(7y7)
F.L. apoptosis
abdominal
hemorrhage
(1y6)
F.L. apoptosis
abdominal
hemorrhage
(5y7)
Necrotic embryo
(5y5)
c-rel2y2rela2y2 Normal
morphology
(10y10)
F.L. apoptosis
abdominal
hemorrhage
(4y14)
F.L. apoptosis
abdominal
hemorrhage
(4y6)
Necrotic
embryo
(4y4)
Fetuses were timed such that day 0 is the day when morning plugs were identified. Saggital sections of fetuses were prepared and stained as described (7).
Fetal liver apoptosis was determined by examination of the histological preparations. F.L., fetal liver. Numbers in parentheses refer to fetuses showing the
specified phenotype vs. total number examined.
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c-rel2y2rela2y2 fetal liver was compared by enumerating mac-
roscopic splenic hemopoietic nodules in irradiated mice injected
with equivalent numbers of viable control or double-mutant
cells. These experiments (Fig. 2) reveal a small, but consistent
2.5-fold reduction in CFU-S in E12 c-rel2y2rela2y2 fetal liver,
indicating that Rel or RelA is necessary for the establishment or
maintenance of normal CFU-S numbers.
The Combined Absence of Rel and RelA Leads to Impaired Erythro-
poiesis. When sacrificed, all recipients of c-rel2y2rela2y2 fetal
liver cells presented with a reduced hematocrit compared with
age-matched controls (Fig. 3A). Mice injected with up to 2 3 106
c-rel2y2rela2y2 cells exhibited severe anemia, whereas those
receiving 4–8 3 106 double-mutant cells were only mildly
anemic. Consistent with the observed anemia, the bone marrow
of all recipients of c-rel2y2rela2y2 cells had markedly fewer
erythroblasts than engrafted controls (Fig. 3B). A defect in
erythropoiesis also was evident in the c-rel2y2rela2y2 fetuses.
When compared with control fetuses, a significantly higher
proportion of E12 c-rel2y2rela2y2 peripheral RBCs were nucle-
ated embryonic cells (Fig. 3C). To determine whether this defect
was associated with a reduction in erythroid progenitors, E12
control and c-rel2y2rela2y2 fetal liver cells were cultured in vitro
with optimal concentrations of erythropoietin, IL-3, and SCF.
c-rel2y2rela2y2 erythroid colonies were of similar number (Ta-
ble 2), size, and appearance to controls. Collectively, these data
indicate that although the absence of Rel and RelA does not
reduce the frequency of committed erythroid progenitors, either
transcription factor is necessary for normal erythrocyte differ-
entiation or production in vivo.
The Absence of Rel and RelA Leads to Granulocytosis. Recipients of
c-rel2y2rela2y2 fetal liver cells that survived between 19 and 22
days postengraftment were only mildly anemic, indicating other
hemopoietic defects aff lict these mice. A common feature of this
group of mice, but not those of equivalent age receiving control
cells, was an excess of differentiating granulocytes in hemopoi-
etic organs (Fig. 4) and other tissues. The absence of a detectable
infection in these mice (results not shown) indicated that this
fetal liver-derived granulocytosis instead represented a deregu-
lated expansion of these cells because of the combined loss of Rel
and RelA. The strongest evidence for such a model came from
mice reconstituted with c-rel2y2rela2y2 fetal liver cells and
normal bone marrow. Over a period of 5–26 weeks postengraft-
ment, ’40% of mice became moribund. Remarkably, in all cases
this was accompanied by granulocytosis of fetal liver but not
bone marrow origin, despite the presence of wild-type granulo-
cytes in these mice (Fig. 5D). The close association between a
selective expansion of c-rel2y2rela2y2 granulocytes in coen-
grafted mice and the onset of sickness was reinforced with the
finding in healthy mice that the number of c-rel2y2rela2y2 fetal
liver-derived granulocytes was always low (Fig. 5D). These data
indicate that the loss of both Rel and RelA can lead to a
deregulated granulocytosis.
Lineage Commitment of c-rel2y2rela2y2 Hemopoietic Stem Cells in
Vivo. Because of the failure of double-mutant fetal liver cells to
successfully promote hemopoietic cell engraftment in lethally
irradiated recipients, C57BLy6-Ly5.1 mice were coreconstituted
with E12 c-rel2y2rela2y2(Ly5.21) fetal liver cells and normal
C57BLy6-Ly5.1 bone marrow. Typical f low cytometry profiles of
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Fig. 2. Reduced numbers of CFU-S in c-rel2y2rela2y2 fetal liver. Numbers of
CFU-S (CFU-Sd12) are shown per 1 3 105 E12 control (c-rel2y2) and c-rel2y2
rela2y2 fetal liver cells transplanted into irradiated recipient mice. The data
represent the mean 6 SEM from five individual donor fetal livers of each
genotype, each transplanted into four recipients, pooled from three indepen-
dent experiments.
Fig. 3. The absence of Rel and RelA impairs erythropoiesis. (A) Hematocrits
of irradiated C57BLy6-Ly5.1 mice engrafted with E12 control (wild-type, c-
rel2y2; open bars) or c-rel2y2rela2y2 (solid bars) fetal liver cells before death.
Recipients of c-rel2y2rela2y2 fetal liver cells represented two distinct groups;
mice surviving between 12 and 16 days postengraftment received fewer fetal
liver cells than recipients surviving between 19 and 22 days. Hematocrits
(normal range, 35–50%) were determined by flow cytometry by using the
Technicon H1 system. Each data point represents the mean 6 SEM from at least
six mice of the appropriate genotypes. (B) The frequency of nucleated ery-
throid cells is reduced markedly in the marrow of mice transplanted with
c-rel2y2rela2y2 fetal liver cells. Control (c-rel2y2, open bars) and c-rel2y
2rela2y2 (solid bars) are shown. The data represent the mean 6 SEM from at
least five mice of each genotype. (C) Blood of E12 c-rel2y2rela2y2 fetuses has
a higher proportion of nucleated embryonic erythrocytes. The ratio of nucle-
ated primitive to enucleated definitive RBCs in E12 control (c-rel2y2) and
c-rel2y2rela2y2 fetuses represents the mean 6 SEM of this relative frequency
in eight fetuses of each genotype. The blood smears presented here are typical
for E12 c-rel2y2 and c-rel2y2rela2y2 fetuses.
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the bone marrow and thymus from healthy mice not exhibiting
granulocytosis 2–6 months after engraftment (Fig. 5) showed
that erythroid, B and T lymphoid, and granulocytic cells of
c-rel2y2rela2y2 fetal liver origin are present, albeit in 2- to
10-fold lower numbers than control fetal liver derived cells in
coreconstituted mice. The lower number of mature c-rel2y2
rela2y2 hemopoietic cells is not simply due to fewer stem cells,
because an increase in the relative proportion of double-mutant
fetal liver cells engrafted in these mice did not alter the
frequency of mature c-rel2y2rela2y2 hemopoietic cells (results
not shown). These data show that the absence of RelA and Rel
does not impair the developmental potential of primitive stem
cells required for long-term reconstitution of the hemopoietic
system.
The Absence of Rel and RelA Leads to Apoptosis During Macrophage
Differentiation in Culture. To quantify the frequency of various
progenitors in c-rel2y2rela2y2 fetal liver committed to specific
hemopoietic lineages, colony-forming cell (CFC) assays were
performed. Table 2 summarizes the frequency of CFCs for the
Fig. 4. Granulocytosis in mice engrafted with c-rel2y2rela2y2 fetal liver cells.
(A) Bone marrow and splenic cells of irradiated C57BLy6-Ly5.1 mice 20 days
after engraftment with control (c-rel2y2) or c-rel2y2rela2y2 fetal liver cells
were stained with mAbs specific to Ly5.2 and Gr-1 and analyzed by flow
cytometry. The organ cellularity and distribution of Ly5.2 and Gr-1 among all
viable bone marrow and splenic cells is shown. (B) Bone marrow cytospins from
irradiated mice engrafted with control (c-rel2y2) or c-rel2y2rela2y2 fetal liver
cells 20 days after transplantation. These data are representative of five or
more animals of each group.
Table 2. Number of progenitor cells of various lineages in the fetal liver
Genotype
Colonies
Total no. G GM M Eo Meg E EyMeg Mix Blast
c-rel1y1rela1y1 113 6 6 17 6 3 18 6 2 22 6 3 2 6 1 8 6 1 26 6 3 11 6 2 2 6 1 6 6 1
c-rel1y1rela2y2 100 6 17 16 6 3 15 6 3 16 6 4 3 6 1 8 6 1 16 6 3 13 6 2 1 6 1 11 6 4
c-rel2y2rela1y1 107 6 13 13 6 1 19 6 3 19 6 3 3 6 1 10 6 2 18 6 3 13 6 3 3 6 1 9 6 2
c-rel2y2rela2y2 91 6 9 19 6 1 9 6 1 2 6 1 2 6 1 11 6 2 21 6 1 13 6 2 2 6 1 10 6 3
Number of progenitor (colony-forming) cells in culture of 10,000 day 12 fetal liver cells stimulated by a combination of growth factors. G, granulocyte; GM,
granulocyte–macrophage; M, macrophage; Eo, eosinophil; Meg, megakaryocyte; E, erythrocyte; EyMeg, erythrocyte–megakaryocyte; Mix, mixed cultures; blast,
blast cell. Given values represent mean 6 SEM from separate cultures from at least six individual fetal livers per genotype.
Fig. 5. c-rel2y2rela2y2 stem cells contribute to the development of various
hemopoietic lineages. Cell suspensions from the bone marrow or thymus of
irradiated C57BLy6-Ly5.1 mice engrafted 4–6 months earlier with normal
Ly5.1 bone marrow and either E12 control (c-rel2y2) or c-rel2y2rela2y2 fetal
liver cells were stained with mAbs specific for fetal liver-derived erythroid (A),
B lymphoid (B), T lymphoid (C), and granulocytic cells (D) and analyzed by flow
cytometry. The symbols p and # correspond to mice that were healthy and sick,
respectively, 4 months after being engrafted with normal Ly5.1 bone marrow
and c-rel2y2rela2y2 fetal liver cells. Organ cellularity and distribution of
normal and fetal liver-derived hemopoietic cells are shown. These data are
representative of six or more animals analyzed in each group.
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various hemopoietic lineages. Although the number of granu-
locyte, eosinophil, megakaryocyte, and erythrocyte colonies in
E12 c-rel2y2rela2y2 fetal liver cultures were normal, the fre-
quency of macrophage and granulocyte–macrophage colonies
was reduced. Those c-rel2y2rela2y2 macrophage colonies that
did grow were smaller than control colonies, and microscopic
examination revealed that the majority of mature macrophages
in these colonies had undergone apoptosis (Fig. 6A). Because
this cell death was independent of the type of hemopoietic
growth factor stimulus (Fig. 6B), this suggested that the defect
aff licted a common differentiation pathway. Despite monocyte
death in cultures, preliminary flow cytometry indicated that
mature monocytic cells could develop from c-rel2y2rela2y2 fetal
liver progenitors in vivo. This finding, however, was complicated
by the knowledge that granulocytes and macrophages share
many cell surface markers, including those recognized by com-
monly used mAbs. To clarify the issue of c-rel2y2rela2y2 mono-
cyte differentiation in vivo, Ly5.21Mac-11Gr-1lo cells isolated by
cell sorting from the bone marrow of coreconstituted C57BLy
6-Ly5.1 mice appear to be typical monocytic cells (Fig. 6C).
These data indicate that apoptosis resulting from the absence of
Rel and RelA during monocyte differentiation in culture could
be bypassed in vivo.
Discussion
Here we describe the phenotype of mice that lack Rel and RelA,
two RelyNF-kB subunits that possess transcriptional transacti-
vating properties. Development in c-rel2y2rela2y2 fetuses ap-
peared normal until E13, at which point fetal liver degeneration
resulting from apoptosis occurred. This phenotype was similar to
that seen in rela2y2 fetuses (7, 8) except it occurred earlier in
gestation, suggesting that Rel, in part, compensates for the
absence of RelA. This accelerated embryonic death coincides
with the overlapping expression of c-rel and rela in fetal liver
during development (19). Because embryonic death resulting
from the loss of RelA can be overcome by inactivating TNFR1
(20), these combined findings suggest that Rel participates in
preventing tumor necrosis factor-a toxicity in vivo.
Previous studies had shown that the loss of either Rel or RelA
did not impair hemopoiesis; rather, it led to defects in the
immune responsiveness of mature hemopoietic cells (7–10). This
is supported by our present observations that the behavior of
both rela2y2 and c-rel2y2fetal liver cells was similar to wild-type
fetal liver cells in all experiments (see Results; data not shown).
Engraftment of mouse c-rel2y2rela2y2 fetal liver hemopoietic
progenitors into irradiated recipients, combined with the use of
in vitro cultures, revealed that Rel and RelA serve redundant
roles in regulating cellular maturation and survival during
hemopoiesis. Most profound was the inability of c-rel2y2rela2y2
fetal liver hemopoietic precursors to promote transient engraft-
ment essential for survival after myeloablative irradiation. Al-
though stem cells crucial for primary engraftment reside in the
CFU-S compartment (21), the moderate reduction in the fre-
quency of CFU-S in E12 c-rel2y2rela2y2 fetal liver cannot
account for the failure of transplanted fetal liver cells to rescue
irradiated recipients. Instead, impaired erythropoiesis and de-
regulated granulopoiesis appear to responsible for the death of
engrafted mice. Although the loss of Rel and RelA affected
erythropoiesis, the severity of the resultant anemia in recipient
mice depended on the number of engrafted c-rel2y2rela2y2 fetal
liver cells. This observation is consistent with a defect in which
erythropoiesis was not blocked but, instead, was ineffective. Such
an in vivo defect could involve a delay in differentiation or an
abnormality in mature RBCs. This conclusion is supported
indirectly by the finding that the frequency of erythroid progen-
itors and their capacity to differentiate in culture appear to be
normal. The blood of E12 c-rel2y2rela2y2 fetuses also had a
higher than normal number of nucleated embryonic RBCs. The
persistence of embryonic erythrocytes in midgestation also has
been documented in rb2y2 (22, 23) and nrf-12y2 (24) fetuses,
where it reflects a defect or retardation in the switch to definitive
erythropoiesis. Similar to our results with c-rel2y2rela2y2 fetal
liver cells, the capacity of rb2y2 and nrf-12y2 fetal liver-derived
progenitors to form erythroid colonies in vitro also was normal,
emphasizing the importance of the hemopoietic microenviron-
ment for effective erythropoiesis in vivo (22–24). Our findings
establish a role for Rel and RelA in erythroid cells. Furthermore,
they suggest that these transcription factors serve redundant
functions in erythroid cells, a conclusion that is consistent with
Fig. 6. c-rel2y2rela2y2 macrophages undergo apoptosis during maturation in culture. (A) Representative control (c-rel2y2) and c-rel2y2rela2y2 macrophage
colonies were grown for 7 days in the presence of macrophage colony-stimulating factor (M-CSF). Cultures were fixed and stained as described in Materials and
Methods. (B) The reduction in c-rel2y2rela2y2 macrophage colonies is independent of the growth factor stimulus. Equivalent numbers of viable E12 control
(wild-type, n 5 6; c-rel2y2, n 5 7; and rela2y2, n 5 6) and c-rel2y2rela2y2 fetal liver cells (n 5 7) were grown in agar for 7 days in the presence of optimal
concentrations of M-CSF (solid bars), stem cell factor SCFyIL-3yerythropoietin (open bars), SCF (lightly shaded bars), or Flk ligandyleukemia inhibiting factor
(darkly shaded bars). N.D., no colonies detected. (C) c-rel2y2rela2y2 progenitors can differentiate into monocytes in vivo. Cells in the bone marrow of irradiated
C57BLy6-Ly5.1 mice engrafted 4 months earlier with normal Ly5.1 bone marrow and E12 c-rel2y2rela2y2 fetal liver cells that stained positive with mAbs specific
for Ly5.2 and Mac-1 but were negative for Gr-1 were sorted by flow cytometry and cytospins were prepared.
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the observation that a significant proportion of fetal liver cells
expressing Rel and RelA are erythroid precursors (19).
The loss of Rel and RelA also leads to the development of
granulocytosis. Interestingly, granulocytosis occurs in recipients
of nfkb12y2rela2y2 fetal liver cells (11), ikba2y2 mice (25), and
mutant mice lacking the regulatory carboxyl terminus of the
NF-kB2 precursor protein (6). Collectively, these findings sug-
gest that a deregulation or imbalance of RelyNF-kB subunits
interferes with the transcription of genes that are required for
normal granulocyte differentiation or activation. The basis of
this excessive granulocyte production is not known. Although in
vitro assays indicate the number and differentiative capacity of
granulocyte precursors in c-rel2y2rela2y2 fetal liver appear
normal, because granulocytes and macrophages can share a
common progenitor, the maturation defect aff licting c-rel2y2
rela2y2 monocytes, in turn, could deregulate granulopoiesis.
Because granulocytosis is not always pathogenic (26), if the
death of c-rel2y2rela2y2 fetal liver engrafted mice is a result of
this condition, it would indicate that these cells are functioning
aberrantly and may be producing cytokines or toxic factors.
The capacity of c-rel2y2rela2y2 fetal liver cells to contribute to
all hemopoietic lineages in long-term, coreconstituted mice
indicates that Rel and RelA are not essential for the differen-
tiation of pluripotent stem cells. However, the lower than
expected frequency of all mature c-rel2y2rela2y2 hemopoietic
cells in these mice indicates that hemopoiesis is not normal. This
difference could reflect a reduced capacity of mutant stem cells
to seed or compete with wild-type bone marrow in engrafted
mice, a decreased ability of c-rel2y2rela2y2 stem cells to respond
to proliferation and differentiation inducing stimuli, or a short-
ened life span of mature c-rel2y2rela2y2 hemopoietic cells in
vivo. The latter is consistent with a role for RelyNF-kB factors
in cell survival (27) and supported by the observation that
apoptosis is higher in c-rel2y2rela2y2 monocytes (see below) and
lymphocytes (M.G., unpublished results).
Apoptosis of maturing c-rel2y2rela2y2 macrophages in cul-
ture shows that Rel or RelA is required for monocyte survival
during the response of progenitors to proliferation- and dif-
ferentiation-inducing stimuli. Although RelA is necessary to
protect mature macrophages against tumor necrosis factor-a-
induced apoptosis (28), this evidence demonstrates an antiapo-
ptotic role for RelyNF-kB during monocyte differentiation.
Despite these in vitro findings, the presence of c-rel2y2rela2y2
fetal liver-derived monocytes in the bone marrow and periph-
eral blood of long-term coreconstituted mice indicates that
compensatory signals or factors critical for monocyte differ-
entiation and survival operate in vivo. It remains to be
determined which gene(s) regulated by Rel and RelA are
required for survival during monocyte differentiation. A1, a
Bcl-2-like prosurvival homolog induced in lymphocytes by Rel
during mitogenic stimulation (29), also is up-regulated during
macrophage differentiation (30). Although Rel-dependent A1
expression is important in protecting B cells from activation-
induced apoptosis (29), a protective role in macrophages
remains unclear, because A12y2 mice exhibit enhanced neu-
trophil but not macrophage death (31). Ultimately, the iden-
tification of RelyNF-kB-regulated genes essential for mono-
cyte survival should offer insights into the mechanisms by
which these transcription factors control this process in re-
sponse to growth and differentiation signals.
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